Nature:慢性炎症:老龄化成纤维细胞的异质性影响重编程和伤口愈合效率

2019-11-07 秋枫 BioArt

老龄化的一个重要特征是伴随的慢性炎症,不过慢性炎症对特定细胞的影响却仍旧未知。成纤维细胞存在于大部分组织中,它们能促进创伤愈合。另外,成纤维细胞最广泛的应用是用于重编程诱导产生多能干细胞。过去,一些科学家研究了老龄化和衰老对重编程的影响,但是我们还缺乏对这种影响的系统性评估。

老龄化的一个重要特征是伴随的慢性炎症,不过慢性炎症对特定细胞的影响却仍旧未知。成纤维细胞存在于大部分组织中,它们能促进创伤愈合。另外,成纤维细胞最广泛的应用是用于重编程诱导产生多能干细胞。过去,一些科学家研究了老龄化和衰老对重编程的影响,但是我们还缺乏对这种影响的系统性评估。

来自美国斯坦福大学的Anne Brunet课题组在Nature杂志上发表了长文文章Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing。他们发现,老年小鼠成纤维细胞培养物中含有炎性因子,增强了不同小鼠之间细胞重编程效率的可变性,并且影响了个体之间的创伤愈合效率。

研究人员首先分析了年龄对成纤维细胞分泌炎性因子的影响,通过对分别来自老年小鼠和年轻小鼠成纤维细胞的条件培养物进行检测,发现相比年轻小鼠,老年小鼠的成纤维细胞的体内系统环境以及体外条件培养基中分泌了更多的促炎因子、抗炎因子和生长因子。

接下来,研究人员分析了年龄对细胞重编程的影响,如图1。结果显示,年龄对重编程的平均效率没有明显影响,不过,随着年龄增大,重编程效率变得不稳定,一些老年小鼠表现出增强了的重编程效率,而另外一些老年小鼠则正好相反。研究人员在来自不同组织的成纤维细胞培养中得到了类似的现象。

进一步的转录组、表观遗传组以及代谢组学分析显示,老年成纤维细胞富集的转录活性主要涉及分泌因子、细胞外基质、收缩力、炎症和伤口愈合等。这些特征是活化成纤维细胞的标志,表观遗传组与代谢组学分析也证实,成纤维细胞的活化与重编程的效率密切相关。

接下来,研究人员对来自不同年龄的成纤维细胞培养物进行了单细胞测序分析。结果显示,老年小鼠来源的成纤维细胞培养物中,重编程效率高的培养物中活化的成纤维细胞数量较多,这说明,活化的成纤维细胞的比率影响了重编程的效率。

研究人员通过交换重编程表现好和不好的成纤维细胞培养物的条件培养基,发现外源因素对重编程的效率同样有着非常重要的影响。其中,IL-6能提高重编程效率,而TNF和IL-1β则抑制了重编程效率。因此,影响重编程效率的因素,一是培养物中活化的成纤维细胞与非活化成纤维细胞的比率,二是培养基中炎性因子的比率,这两个条件共同决定了重编程的效率。

研究人员还分析了不同年龄来源的成纤维细胞对伤口愈合的影响。与重编程类似,老龄化并不影响伤口愈合的平均速率,只不过,老年小鼠的伤口愈合速率也变得不稳定。通过单细胞测序分析以及流式细胞分选,研究人员发现,老年小鼠中,伤口愈合速度慢的小鼠成纤维细胞比较丰富,而伤口愈合速度快的小鼠则是免疫细胞比较丰富。

总之,本研究发现,体外细胞重编程以及体内伤口愈合的不稳定与小鼠的老龄化密切相关,在这两个生理过程中,炎性因子都发挥了重要的作用。理解老龄化对重编程以及伤口愈合等生理过程的影响机制,有利于以后进行个性化治疗方案的设计。

原始出处:
Mahmoudi S1, Mancini E1, Xu L1,2, Moore A3,4, et al.Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing.Nature. 2019 Oct;574(7779):553-558. doi: 10.1038/s41586-019-1658-5. Epub 2019 Oct 23.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1883980, encodeId=2edb1883980be, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Sep 30 04:59:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307131, encodeId=7b47130e1316f, content=<a href='/topic/show?id=6dab540565f' target=_blank style='color:#2F92EE;'>#成纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54056, encryptionId=6dab540565f, topicName=成纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309898, encodeId=efa1130989820, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344696, encodeId=27ee1344696f7, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462815, encodeId=52021462815e8, content=<a href='/topic/show?id=fbbce726228' target=_blank style='color:#2F92EE;'>#纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77262, encryptionId=fbbce726228, topicName=纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c516518840, createdName=marongnuan, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=)]
    2020-09-30 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1883980, encodeId=2edb1883980be, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Sep 30 04:59:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307131, encodeId=7b47130e1316f, content=<a href='/topic/show?id=6dab540565f' target=_blank style='color:#2F92EE;'>#成纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54056, encryptionId=6dab540565f, topicName=成纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309898, encodeId=efa1130989820, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344696, encodeId=27ee1344696f7, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462815, encodeId=52021462815e8, content=<a href='/topic/show?id=fbbce726228' target=_blank style='color:#2F92EE;'>#纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77262, encryptionId=fbbce726228, topicName=纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c516518840, createdName=marongnuan, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1883980, encodeId=2edb1883980be, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Sep 30 04:59:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307131, encodeId=7b47130e1316f, content=<a href='/topic/show?id=6dab540565f' target=_blank style='color:#2F92EE;'>#成纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54056, encryptionId=6dab540565f, topicName=成纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309898, encodeId=efa1130989820, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344696, encodeId=27ee1344696f7, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462815, encodeId=52021462815e8, content=<a href='/topic/show?id=fbbce726228' target=_blank style='color:#2F92EE;'>#纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77262, encryptionId=fbbce726228, topicName=纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c516518840, createdName=marongnuan, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1883980, encodeId=2edb1883980be, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Sep 30 04:59:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307131, encodeId=7b47130e1316f, content=<a href='/topic/show?id=6dab540565f' target=_blank style='color:#2F92EE;'>#成纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54056, encryptionId=6dab540565f, topicName=成纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309898, encodeId=efa1130989820, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344696, encodeId=27ee1344696f7, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462815, encodeId=52021462815e8, content=<a href='/topic/show?id=fbbce726228' target=_blank style='color:#2F92EE;'>#纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77262, encryptionId=fbbce726228, topicName=纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c516518840, createdName=marongnuan, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1883980, encodeId=2edb1883980be, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Sep 30 04:59:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307131, encodeId=7b47130e1316f, content=<a href='/topic/show?id=6dab540565f' target=_blank style='color:#2F92EE;'>#成纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54056, encryptionId=6dab540565f, topicName=成纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309898, encodeId=efa1130989820, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344696, encodeId=27ee1344696f7, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462815, encodeId=52021462815e8, content=<a href='/topic/show?id=fbbce726228' target=_blank style='color:#2F92EE;'>#纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77262, encryptionId=fbbce726228, topicName=纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c516518840, createdName=marongnuan, createdTime=Sat Nov 09 05:59:00 CST 2019, time=2019-11-09, status=1, ipAttribution=)]

相关资讯

老龄化人口健康保障需求推动中宏构建“老有所养,病有所医”体系

目前,拥有全球第二大保险市场的中国,正在步入“未富先老”的阶段。多层次的养老保险市场有待完善。无论从政策驱动还是市场需求来看,亟需填补的医疗和养老保障的缺口,对保险公司而言意味着巨大的商业潜力和市场空间。目前,拥有全球第二大保险市场的中国,正在步入“未富先老”的阶段。多层次的养老保险市场有待完善。中宏保险首席执行官张凯表示,在中国加速进入人口老龄化阶段的过程中,保险公司会起到非常重要的作用。中宏保

社会力量将成医养结合“主力军” 五种方式构筑医养结合全模式

目前很多医疗机构与养老机构互相独立,养老院不方便就医,医院里又不养病人,为老人造成了困难,“医养结合”这种新模式由此诞生,它衔接了“医疗”与“养老”,从而实现老有所养、老有所医。

新加坡新跃社科大学签署两份谅解备忘录

新加坡新跃社科大学(SUSS)于2月23日就多项合作事宜签署了两份谅解备忘录,以便进一步了解和支持日趋庞大的老人群体及其看护者的需求。两份谅解备忘录旨在倡导积极老龄化与代际亲情。新加坡新跃社科大学(SUSS)于2月23日就多项合作事宜签署了两份谅解备忘录,以便进一步了解和支持日趋庞大的老人群体及其看护者的需求。两份谅解备忘录旨在倡导积极老龄化与代际亲情。新跃社科大学校长张起杰(Cheong H

防治心血管疾病有了新利器

心血管疾病是导致全球人口死亡的重要原因。《2017中国心血管疾病报告》显示,据推算,中国心血管疾病患者高达2.9亿,其中脑卒中患者约1300万,冠心病患者约1100万,高血压患者约2.7亿。

老龄化加快 美国老年医保基金预计7年后破产

医疗支出一路攀升、医保基金则入不敷出,这早已成为世界难题。 2018年,中国基本医疗保险基金总收入21090.11亿元,比上年增长17.62%;总支出17607.65亿元,同比增长22.08%。国家医疗保障局发布的数据显示,中国医保支出的增速远大于收入增速,医保控费势在必行。

应对人口老龄化 国家卫生健康委对护理工作提出这些要求

国家卫生健康委员会2019年5月8日召开例行新闻发布会,介绍全国护理工作发展情况。主持人 国家卫生健康委新闻发言人、宣传司司长 宋树立:各位媒体朋友,大家上午好!欢迎参加国家卫生健康委例行新闻发布会。今天的发布会,我们将继续按照今年发布会的主线“壮丽70年 奋斗新时代”进行。很快就是5·12国际护士节了,护理工作者是我国卫生健康战线的重要力量,在维护群众健康权益和提升群众健康水平中担负着重要职